Revenue - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Concentration Risk [Line Items] | ||||||
| Revenue recognized | $ 94 | $ 2,050 | $ 751 | $ 3,716 | ||
| Accounts receivable | $ 14,223 | $ 14,223 | $ 17,272 | |||
| Impairment loss on contract assets | 555 | $ 325 | ||||
| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||||||
| Remaining performance obligation | 164,160 | 164,160 | ||||
| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01 | ||||||
| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||||||
| Remaining performance obligation | $ 99,184 | $ 99,184 | ||||
| Timing of satisfaction, period | 12 months | 12 months | ||||
| Revenue from Contract with Customer | Customer Concentration Risk | Transferred over Time | ||||||
| Concentration Risk [Line Items] | ||||||
| Percentage of concentration risk | 67.00% | 61.00% | ||||
| X | ||||||||||
- Definition Contract With Customer, Liability, Revenue Recognized Including Opening Balance No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|